ClinicalTrials.Veeva

Menu

Hemodynamic Management Following Acute Traumatic Spinal Cord Injury

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Enrolling

Conditions

Spinal Cord Injuries

Treatments

Other: Mean arterial blood pressure (MAP) goal of 85-90 mmHg
Other: Spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg
Other: Mean arterial blood pressure (MAP) goal of ≥65 mmHg

Study type

Interventional

Funder types

Other

Identifiers

NCT06451133
HSC-MS-24-0405

Details and patient eligibility

About

The purpose of this study is to assess the effect of various hemodynamic management strategies on functional neurologic outcomes and non-neurologic adverse events in the first 5 days following acute spinal cord injury (SCI). The hemodynamic management strategies assessed include targeting a mean arterial blood pressure (MAP) goal of 85-90 mmHg, targeting a spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg, or targeting normal hemodynamics, which is a MAP goal of ≥65 mmHg.

Enrollment

228 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Traumatic spinal cord injury

Exclusion criteria

  • Patients with an injury from a trauma that penetrates the spinal cord (i.e., gunshot or knife wound resulting in cord transection)
  • Preexisting neurologic or spinal cord injury
  • Severe traumatic brain injury as measured by a best resuscitated Glasgow Coma Scale (GCS) score of <8 at 24 hours following injury
  • Presence of traumatic injuries that preclude spine surgery within 24 hours of presentation
  • Concomitant injury/illness requiring targeted blood pressure management (e.g., injury to the aorta, aortic dissection, hemorrhagic stroke)
  • Preexisting history of neuromotor disorders (i.e., cerebral palsy, Parkinson disease, etc.)
  • Not expected to survive >24h
  • Cord transection identified by radiologist and agreed upon by the spine surgery team
  • Injury below spinal cord level L1
  • Prisoners
  • Pregnant women

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

228 participants in 3 patient groups

Mean arterial blood pressure (MAP) goal of ≥65 mmHg
Experimental group
Treatment:
Other: Mean arterial blood pressure (MAP) goal of ≥65 mmHg
Mean arterial blood pressure (MAP) goal of 85-90 mmHg
Experimental group
Treatment:
Other: Mean arterial blood pressure (MAP) goal of 85-90 mmHg
Spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg
Experimental group
Treatment:
Other: Spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg

Trial contacts and locations

1

Loading...

Central trial contact

David Meyer, MD, MS, FACS; Erin Fox

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems